InvestorsHub Logo
Followers 2
Posts 104
Boards Moderated 0
Alias Born 06/30/2009

Re: philife post# 1193

Friday, 10/30/2009 11:37:57 AM

Friday, October 30, 2009 11:37:57 AM

Post# of 18434
That abstract was written in the necessarily very conservative language of scientists. That is consistent with what would be presented with most of the topics at today’s Nephrology Conference.

The Great news, as has been stated before, is that we have a respected MD (not the well spoken and respected JJ) presenting actual data results of clinical application of the hemopurifier. Notice that Dr Kher is the first name listed in the abstract, while JJ is not listed by name as a speaker. Although surely JJ will be present, and active where appropriate. This conference presentation is a great milesone, in a larger unfolding story regarding commercialization of AEMD products in India and elsewhere.

If anyone was expecting business strategy or investment news related to commercialization in India today, that would not have been appropriate for the audience at the Nephrology conference. Sure, it would be nice to get such news concurrent with today’s presentation, but … it sure seems we have seen a lot of evidence to indicate that such news is coming, relatively soon. Those who were looking for lots of unknowns to be answered in a new PR today, are probably selling today.

I’m looking forward to the coming week, the coming weeks, and the rest of 2009, for more good news re AEMD.

My thanks to the helpful sharing on this board.
BBarry
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEMD News